Woman Man | 21 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
Extract
A phase II, open-label, randomized, multicenter trial of GW786034 (pazopanib) in combination with lapatinib (GW572016) compared to lapatinib alone as first line therapy in subjects with advanced or metastatic breast cancer with ErbB2 fluorescence in situ hybridization (FISH) positive tumors.
Scientific Abstract
en cours d'intégration;